Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs Rejuve Meds

Mevo Health
Graded #326

Lower grade

vs+5.8999999999999915
Rejuve Meds
Graded #208

Higher grade

The verdict

Rejuve Meds takes it — 66.1/100 to 60.2/100.

Rejuve Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRejuve Meds +9
56
65
Dose & formulationMevo Health +19
83
64
Clinical oversightRejuve Meds +12
67
79
Labs & monitoringEven
52
52
FulfillmentRejuve Meds +14
57
71
Contract termsRejuve Meds +41
20
61
Mevo Health · left barRejuve Meds · right bar

The numbers

MetricMevo HealthRejuve Meds
WeighScore60.2/10066.1/100
GradeCC
Scorecard rank#326#208
Semaglutide$199/mo (all doses, compounded)$165/mo (starting dose, compounded)
Tirzepatide$259/mo (all doses, compounded)$265/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
Rejuve Meds

Graded #208 · C

Strengths

  • Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
  • No membership fees — everything is included; free shipping
  • HSA/FSA eligible; intro pricing from $85 for the first month
  • Doctor-guided programs with personalized care
  • Names a "Rejuve Meds Pharmacy Network" for fulfillment

Where it loses points

  • Individual compounding pharmacies not named (only a "pharmacy network")
  • Prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard